Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.

OBJECTIVE: To determine the effect of low-dose aspirin vs placebo on incident all-cause dementia, incident Alzheimer disease (AD), mild cognitive impairment (MCI), and cognitive decline in older individuals. METHODS: Aspirin in Reducing Events in the Elderly (ASPREE) was a double-blind, placebo-...

Full description

Bibliographic Details
Main Authors: Ryan, Joanne, Storey, Elsdon, Murray, Anne M, Woods, Robyn L, Wolfe, Rory, Reid, Christopher, Nelson, Mark R, Chong, Trevor TJ, Williamson, Jeff D, Ward, Stephanie A, Lockery, Jessica E, Orchard, Suzanne G, Trevaks, Ruth, Kirpach, Brenda, Newman, Anne B, Ernst, Michael E, McNeil, John J, Shah, Raj C, ASPREE Investigator Group
Format: Journal Article
Language:English
Published: 2020
Subjects:
ASPREE Investigator Group
Online Access:http://purl.org/au-research/grants/nhmrc/1136372
http://hdl.handle.net/20.500.11937/80070

Internet

http://purl.org/au-research/grants/nhmrc/1136372
http://hdl.handle.net/20.500.11937/80070

Similar Items